GlassScriptPhysician profile
Laura R Mandrick
NPI 1972996122
$2,885.46
in general payments reported to CMS, 2019-2025
16 companies · $665 in 2025
The $665 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $72.52 · 2023: $123 · 2024: $1,689 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379 · Travel and Lodging: $1,027 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.43 |
| Travel and Lodging | $1,027.40 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,800.35 | 2024-2025 | Inspire |
| Organogenesis INC. | $273.09 | 2021 | |
| Jazz Pharmaceuticals INC. | $139.12 | 2025 | |
| Abbvie INC. | $119.46 | 2021-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $115.32 | 2025 | Lumryz |
| Janssen Biotech, INC. | $110.23 | 2023-2024 | Stelara |
| Urgo Medical North America, LLC | $72.52 | 2022 | |
| Zoll Respicardia, INC. | $69.50 | 2024-2025 | Remede System |
| Lundbeck LLC | $38.06 | 2023 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $33.97 | 2023-2024 | Entyvio |
| Axsome Therapeutics, INC. | $31.56 | 2025 | Sunosi |
| Convatec INC. | $22.64 | 2021 | |
| Glaxosmithkline, LLC. | $19.20 | 2025 | Nucala |
| Smith+Nephew, INC. | $13.97 | 2021 | |
| Eisai INC. | $13.83 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mandrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.